Influence of contraception on the levels of vitamins in the organism;Vliv hormonální antikoncepce na hladinu vitaminů v organismu

Ceska Gynekologie

Volumn 69, Issue 5, 2004, Pages 397-401

  Hronek, Miloslav ^a,b   Poljakova G ^a  

^a UK   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

25 hydroxyvitamin D; Beta carotene; Hormonal contraceptive; Pyridoxine; Retinol; Transcobalamin; Vitamin C; Vitamin E

Indexed keywords

25 HYDROXYVITAMIN D; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; COBALAMIN; ETHINYLESTRADIOL; RETINOL; STEROID; TRANSCOBALAMIN; VITAMIN;

CLIMACTERIUM; DRUG SAFETY; FEMALE; HORMONAL CONTRACEPTION; HUMAN; NUTRIENT; REVIEW; SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL;

CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HUMANS; VITAMINS;

EID: 7644233757     PISSN: 12107832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Back, D. J., Madden, S., Orme, M. L.: Gastrointestinal metabolism of contraceptive steroids. Am. J. Obstet. Gynecol., 1990, 163, p. 2138-2145.
2. Back, D. J., Orme, M. L.: Pharmacokinetic drug interactions with oral contraceptives. Clin. Pharmacokinet., 1990, 18, p. 472-484.
3. Berg, G., Kohlmeier, L., Brenner, H.: Use of oral contraceptives and serum beta-carotene. Eur. J. Clin. Nutr., 1997, 51, p. 181-187.
4. Carmel, R., Howard, J. M., Green, R., t al.: Hormone replacement therapy and cobalamin status in elderly women. Am. J. Clin.Nutr., 1996, 64, p. 856-859.
5. Ciavatti, M., Renaud, S.: Oxidative status and oral contraceptive. Its relevance to platelet abnormalities and cardiovascular risk. Free Radic. Biol. Med., 1991, 10, p. 325-338.
6. Cracium, A. M., Wolf, J., Knapee, M. H., et al.: Improved bone metabolism in female elite athletes after vitamin K supplementation. Int. J. Sports Med., 1998, 19, p. 479-484.
7. Dey, C. D., Das, P. C., Das, K., et al.: Biogenic amines and ascorbic acid in rat brain following steroid contraceptive treatment. Exp. Clin. Endocrinol., 1991, 97, p. 103-106.
8. Gardyn, J., Mittelman, M., Zlotnik, J., et al.: Oral contraceptives can cause falsely low vitamin B(12) levels. Acta Haematol., 2000, 104, p. 22-24.
9. Gonzáles, M. J., Schmitz, K., Matos, M. I., et al.: Folate supplementation and neural tube defects: a review of a public health issue. P R Health Sci. J., 1997, 16, p. 387-393.
10. Harris, S. S., Dawson-Hughes, B.: The association of oral contraceptive use with plasma 25-hydroxyvitamin D levels. J. Am. Coll. Nutr., 1998, 17, p. 282-284.
11. Hercberg, S., Preziosi, P., Galan, P., et al.: Vitamin status of healthy french population. Dietary intakes and biochemical markers. Int. J. Vitam. Nutr. Res., 1994, 64, p. 220-232.
12. Kuhnz, W., Louton, T., Kumpel, M., et al.: Influence of high doses of vitamin C on the bioavailability and the serum protein binding of levonorgestrel in women using a combination oral contraceptive. Contraception, 1995, 51, p. 111-116.
13. Masaryk, P., Lunt, M., Benevolenskaya, L., et al.: Effects of menstrua] history and use of medications on bone mineral density: the EVOS Study. Calcif. Tissue Int., 1998, 63, p. 271-276.
14. Massé, P. G., Van den Berg, H., Duguay, C., et al.: Early effect of low dose (30 micrograms) ethinyl estradiol-containing Triphasil on vitamin B6 status. A follow-up study on six menstrual cycles. Int. J. Vitam. Nutr. Res., 1996, 66, p. 46-54.
15. Mooij, P. N., Thomas, C. M., Doesburg, Wh., et al.: Multivitamin supplementation in oral contraceptive users. Contraception, 1991, 44, p. 227-288.
16. Nebeling, L. C., Forman, M. R., Graubard, B. I., et al.: Changes in carotenoid intake in the United States: the 1987 and 1992 National Health Interview Surveys. J. Am. Diet. Assoc., 1997, 97, p. 991-996.
17. Nebeling, L. C., Forman, M. R., Grauberd, B. I., et al.: The impact of lifestyle characteristics on carotenoid intake in the United States: the 1987 National Health Interview Survey. Am. J. Public Health, 1997, 87, p. 268-271.
18. Nesby-O'Dell, S., Scanion, K. S., Cogswell, M. E., et al.: Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am. J. Clin. Nutr., 2002, 76, p. 187-192.
19. Palan, P. R., Chang, C. J., Mikhail, M. S., et al.: Plasma concentrations of micronutrients during a nine-month clinical trial of beta-carotene in women with precursor cervical cancer lesions. Nutr. Cancer, 1998, 30, p. 46-52.
20. Shenfield, G. M.: Oral contraceptives. Are drug interactions of clinical significance? Drug Saf., 1993, 9, p. 21-37.
21. Thomson, S. W., Heimburger, D., Cornwell, P. E., et al.: Correlates of total plasma homocysteine: folic acid, copper, and cervical dysplasia. Nutrition, 2000, 16, p. 411-416.
22. Thurnham, D. I., Northrop-Clewes, C. A.: Optimal nutrition: vitamin A and the carotenoids. Proc. Nutr. Soc., 1999, 58, p. 449-457.
23. Wen, Y., Doyle, M. C., Harrison, R. F., et al.: The effect of hormone replacement therapy on vitamin E status in postmenopausal women. Maturitas, 1997, 26, p. 121-124.
24. Winnefeld, K., Schirrmeister, W., Thiele, R., et al.: Selenium and antioxidant status in various diseases. Med. Klin., 1995, 90 (Suppl. 1), p. 7-9.
25. Zamah N. M., Hümpel, M., Kuhnz, W., et. al.: Absence of effect of high vitamin C dosage on the systemic availability of ethinyl estradiol in women using a combination oral contraceptive. Contraception, 1993, 48, p. 377-391.
26. Zitermann, A.: Decreased urinary calcium loss and lower bone turnover in young oral contraceptive users. Metabolism, 2000, 49, p. 1078-1082.